Use of evofosfamide for targeting immune-suppressive hypoxia in head and neck squamous cell carcinoma

被引:0
|
作者
Hunter, Francis [1 ]
Shome, Avik [1 ]
Wong, Way [1 ]
Budhani, Pratha [2 ]
Senzer, Neil [3 ]
Chiorean, E. Gabriela [4 ]
Li, Dan [1 ]
Tsai, Peter [1 ]
Poonawala, Nooriyah [1 ]
Kakadiya, Purvi [1 ]
Kondratyev, Maria [5 ]
Lynch, Courtney [1 ]
Hong, Cho Rong [1 ]
Lee, Tet-Woo [1 ]
Kee, Dennis [6 ]
Macann, Andrew [6 ]
McIvor, Nicholas [6 ]
Hicks, Kevin [1 ]
Bohlander, Stefan [1 ]
Print, Cristin [1 ]
Kroll, Stew [7 ]
Hart, Charles [7 ]
Wouters, Bradly [5 ]
Wilson, William [1 ]
Curran, Michael [2 ]
Jamieson, Stephen [1 ]
机构
[1] Univ Auckland, Auckland, New Zealand
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[3] Mary Crowley Canc Res Ctr, Dallas, TX USA
[4] Indiana Univ, Melvin & Bren Simon Canc Ctr, Indianapolis, IN 46204 USA
[5] Univ Hlth Network, Toronto, ON, Canada
[6] Auckland City Hosp, Auckland, New Zealand
[7] Threshold Pharmaceut, San Francisco, CA USA
来源
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P464
引用
收藏
页数:2
相关论文
共 50 条
  • [21] Myeloid differentiation treatment to diminish the presence of immune-suppressive CD34(+) cells within human head and neck squamous cell carcinomas
    Young, MRI
    Wright, MA
    Pandit, R
    JOURNAL OF IMMUNOLOGY, 1997, 159 (02): : 990 - 996
  • [22] Profiles of immune cell infiltration in head and neck squamous carcinoma
    Liang, Bin
    Tao, Ye
    Wang, Tianjiao
    BIOSCIENCE REPORTS, 2020, 40
  • [23] Immune profiles in primary squamous cell carcinoma of the head and neck
    Saloura, Vassiliki
    Izumchenko, Evgeny
    Zuo, Zhixiang
    Bao, Riyue
    Korzinkin, Michael
    Ozerov, Ivan
    Zhavoronkov, Alex
    Sidransky, David
    Bedi, Atul
    Hoque, Mohammad O.
    Koeppen, Hartmut
    Keck, Michaela K.
    Khattri, Arun
    London, Nyall
    Kotlov, Nikita
    Fatima, Aiman
    Vougiouklakis, Theodore
    Nakamura, Yusuke
    Lingen, Mark
    Agrawal, Nishant
    Savage, Peter A.
    Kron, Stephen
    Kline, Justin
    Kowanetz, Marcin
    Seiwert, Tanguy Y.
    ORAL ONCOLOGY, 2019, 96 : 77 - 88
  • [24] Immune Checkpoints Pathways in Head and Neck Squamous Cell Carcinoma
    Veigas, Florencia
    Mahmoud, Yamil D.
    Merlo, Joaquin
    Rinflerch, Adriana
    Rabinovich, Gabriel Adrian
    Girotti, Maria Romina
    CANCERS, 2021, 13 (05) : 1 - 31
  • [25] Immune Checkpoint Inhibitors for Head and Neck Squamous Cell Carcinoma
    Chang, Hui-Chin
    Gau, Shuo-Yan
    JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2025, 151 (02)
  • [26] miR-133a as a tumor suppressive microRNA by targeting multiple oncogenes in head and neck squamous cell carcinoma (HNSCC)
    Hanazawa, Toyoyuki
    Kikkawa, Naoko
    Nohata, Nijoro
    Suzuki, Homare
    Chiyomaru, Takeshi
    Enokida, Hideki
    Nakagawa, Masayuki
    Okamoto, Yoshitaka
    Seki, Naohiko
    CANCER RESEARCH, 2010, 70
  • [27] miR-1 as a tumor suppressive microRNA targeting TAGLN2 in head and neck squamous cell carcinoma
    Nohata, Nijiro
    Sone, Yaeko
    Hanazawa, Toyoyuki
    Fuse, Miki
    Kikkawa, Naoko
    Yoshino, Hirofumi
    Chiyomaru, Takeshi
    Kawakami, Kazumori
    Enokida, Hideki
    Nakagawa, Masayuki
    Shozu, Makio
    Okamoto, Yoshitaka
    Seki, Naohiko
    ONCOTARGET, 2011, 2 (1-2) : 29 - 42
  • [28] Targeting the EGFR and Immune Pathways in Squamous Cell Carcinoma of the Head and Neck (SCCHN): Forging a New Alliance
    Saba, Nabil F.
    Chen, Zhuo Gerogia
    Haigentz, Missak
    Bossi, Paolo
    Rinaldo, Alessandra
    Rodrigo, Juan P.
    Makitie, Antti A.
    Takes, Robert P.
    Strojan, Primoz
    Vermorken, Jan B.
    Ferlito, Alfio
    MOLECULAR CANCER THERAPEUTICS, 2019, 18 (11) : 1909 - 1915
  • [29] Synthetic lethal targeting of AURKA in head and neck squamous cell carcinoma
    da Silva, Flaviane N.
    Nguyen, Theodore
    Lee, Jong Woo
    Burtness, Barbara
    Golemis, Erica
    CANCER RESEARCH, 2023, 83 (07)
  • [30] EGFR targeting drugs in the treatment of head and neck squamous cell carcinoma
    Sundvall, Maria
    Karrila, Anna
    Nordberg, Janne
    Grenman, Reidar
    Elenius, Klaus
    EXPERT OPINION ON EMERGING DRUGS, 2010, 15 (02) : 185 - 201